| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.043 | 0.8 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |